Mile High Labs acquired a 400,000 square foot pharmaceutical manufacturing facility of Sandoz Inc., a division of Novartis (Switzerland), in Broomfield, Colorado, with a view to meet the rising global consumer demand for CBD (Cannabidiol) in the form of tinctures, lotions, and gummies.